1 year return (CAGR)
-50.64%
Cyclo Therapeutics Inc Exchange (NASDAQ, USD)
CYTH
-
+0.01 (+1.39%)
HealthcareDrug Manufacturers - Specialty & Generic
Loading...
3 year return (CAGR)
-36.47%
5 year return (CAGR)
-44.39%
10 year return (CAGR)
-25.12%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
23.59M
Price/Sales
27.09
Ent value
41.39M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-25.08%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.66 |
| Daily high | 0.73 |
| Daily low | 0.63 |
| Daily Volume | 187K |
| 1y analyst estimate | 0.95 |
| Beta | -0.57 |
| EPS (TTM) | -0.86 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CYTH | S&P500 | |
| Current price drop from All-time high | -99.81% | -6.11% |
| Highest price drop | -99.85% | -56.47% |
| Date of highest drop | 26 Dec 2024 | 9 Mar 2009 |
| Avg drop from high | -93.75% | -10.68% |
| Avg time to new high | 1166 days | 12 days |
| Max time to new high | 4649 days | 1805 days |
News
No items found